SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030426
Filing Date
2019-08-08
Accepted
2019-08-08 07:51:45
Documents
64
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20190630.htm   iXBRL 10-Q 2741727
2 EX-10.2 atra-ex102_118.htm EX-10.2 83644
3 EX-31.1 atra-ex311_12.htm EX-31.1 16117
4 EX-31.2 atra-ex312_11.htm EX-31.2 16150
5 EX-32.1 atra-ex321_9.htm EX-32.1 8008
  Complete submission text file 0001564590-19-030426.txt   9363335

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atra-20190630.xsd EX-101.SCH 51767
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20190630_cal.xml EX-101.CAL 70155
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20190630_def.xml EX-101.DEF 171783
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20190630_lab.xml EX-101.LAB 461268
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20190630_pre.xml EX-101.PRE 338141
11 EXTRACTED XBRL INSTANCE DOCUMENT atra-10q_20190630_htm.xml XML 1824848
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 191007502
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences